Chronic Obstructive Pulmonary Disease Market is expected to grow at a CAGR of 4.40% from 2024 to 2032 | Polaris Market Research

According to a new market research report published by Polaris Market Research, the global chronic obstructive pulmonary disease (COPD) market is expected to grow at a CAGR of 4.40% from 2024-2032. One of the main traits fuelling the augmentation of the COPD market is consistent cigarette smoking.

Chronic obstructive pulmonary disease is a detrimental provocative lung disease that leads to barricaded airflow from the lungs. Indicators involve breathing struggle, cough, mucus production, and wheezing. It is normally generated by extended liability to annoying gases or particulate matter, most frequently from cigarette smoke.

Download Our Sample Report for Key Insights into the US$ 31.29 Billion Chronic Obstructive Pulmonary Disease (COPD) Market ! https://www.polarismarketresearch.com/industry-analysis/global-chronic-obstructive-pulmonary-disease-market/request-for-sample

Persons with COPD are at an escalated probability of spreading heart disease, lung cancer, and several other conditions. Emphysema and chronic bronchitis are the two most normal conditions that bring about COPD. These two conditions normally take place cohesively and can differ in gravity amongst persons with COPD.

The global chronic obstructive pulmonary disease (COPD) market was valued at USD 21.37 billion in 2023 to USD 31.29 billion by 2032, disclosing a CAGR of 4.40% during the forecast period of 2024-2032.

The market is witnessing strong growth owing to the rise in environmental pollution and the increase in the number of people with asthma. Besides, the market is expanding due to the escalation in the elderly population.

Segmental Overview
• The market for chronic obstructive pulmonary disease is divided essentially by drug type, product type, and region.

• Based on drug type, the bronchodilators segment witnessed a steep rise due to growing consciousness amongst the masses and physicians seizing and dictating the medicine, which is disposed to push the market during the forecast period.

• By product, the nebulizers segment dominated the market due to market players taking the enterprise to make contemporary technologies that are simple to utilize and comfortable to manage.

𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 @ https://www.polarismarketresearch.com/buy/1995/2

Key Market Players:
1. AstraZeneca
2. GlaxoSmithKline (UK)
3. Boehringer Ingelheim International GmbH
4. F. Hoffmann-La Roche Ltd.
5. Pneuma Respiratory
6. Microlife Corporation
7. HELTMAN Medikal A.S

Chronic Obstructive Pulmonary Disease Market Report Highlights

• By drug type, bronchodilator segment is expected to increase over a forecast period due to increased cases of COPD and asthma.

• Nebulizers segment is expected to grow rapidly in the market over the forecast period due to new technologies invented in nebulizers.

• The need for cutting-edge medicines, the rise of the healthcare infrastructure, and more government funding are expected to positively impact the North American market and contribute to its expansion.

• The major international participants include AstraZeneca, Orion Corporation, Novartis, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline, Mylan (Viatris), CHIESI Farmaceutici SpA and others.

𝐂𝐥𝐢𝐜𝐤 𝐡𝐞𝐫𝐞 𝐭𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/industry-analysis/global-chronic-obstructive-pulmonary-disease-market

Regional Overview:

Polaris Market Research has segmented chronic obstructive pulmonary disease market report based on drug type, product type, and region:

Chronic obstructive pulmonary disease, by Drug Type (Revenue - USD Billion, 2019-2032)
• Phosphodiesterase-4 Inhibitor
• Bronchodilators
o Long-Acting Bronchodilators
o Short-Acting Bronchodilators
• Methylxanthines
• Corticosteroids

Chronic obstructive pulmonary disease, by Product Type (Revenue - USD Billion, 2019-2032)
• Inhalers
o Dry Powders Inhalers
o Metered-Dose Inhalers
o Soft Mist Inhalers
• Nebulizers
o Ultrasonic Nebulizers
o Jet Nebulizers

Chronic obstructive pulmonary disease, by Region (Revenue - USD Billion, 2019-2032)
• North America
o U.S.
o Canada
• Europe
o Netherland
o Spain
o Russia
o Italy
o UK
o France
o Germany
• Asia Pacific
o Malaysia
o Indonesia
o Japan
o China
o India
o South Korea
• Latin America
o Argentina
o Mexico
o Brazil

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 (𝐀𝐈) 𝐢𝐧 𝐌𝐞𝐧𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.openpr.com/news/3416040/artificial-intelligence-ai-in-mental-health-market

𝐍𝐞𝐨𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.openpr.com/news/3416048/neobanking-market-share-to-reach-usd-4784-54-billion-globally

𝐒𝐨𝐮𝐫𝐝𝐨𝐮𝐠𝐡 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.openpr.com/news/3416085/sourdough-market-rising-trends-growth-projections-and-key

𝐒𝐩𝐢𝐜𝐞𝐬 𝐚𝐧𝐝 𝐒𝐞𝐚𝐬𝐨𝐧𝐢𝐧𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.openpr.com/news/3416095/spices-and-seasoning-market-research-report-2024-2032

𝐒𝐮𝐩𝐞𝐫𝐟𝐨𝐨𝐝𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.openpr.com/news/3416101/superfoods-market-business-revenue-industry-dynamics

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐈𝐧𝐟𝐨:
Polaris Market Research
30 Wall Street, 8th Floor,
New York City, NY 10005,
United States
Phone:+1-929 297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.